Searched for
BOURLA
US market today: Pfizer posts strong first-quarter, sees boost from recent legal winsPfizer reported higher-than-expected sales and profit on Tuesday and said a patent extension for its Vyndamax heart drug and a recent favor...- Pfizer buys Seagen for $43B, boosts access to cancer drugsThe deal announced Monday will combine Seagen's technology with Pfizer's scale and strength, Pfizer CEO Albert Bourla said in a statement. ...
- Pfizer CEO tests positive for COVID for a second timePfizer Chief Executive Officer Albert Bourla , 60, back in August had contacted COVID and had started a course of the company's oral COVID-...
- Pfizer CEO Albert Bourla tests positive for Covid, says has very mild symptomsPfizer Inc Chief Executive Officer Albert Bourla said he had started a course of the company's oral COVID-19 antiviral treatment, Paxlovid,...
- COVID-19 vaccines for new variants possible for Fall, says Pfizer's Chief Executive Bourla"It's easy to do something only against Omicron. What is scientifically and technically more challenging ... is to be effective against eve...
- Pfizer plans tiered pricing for its Covid antiviral PaxlovidPfizer has signed a voluntary licensing with UN-backed Medicines Patent Pool (MPP) allowing the latter to grant sub-licences of Paxlovid to...
- EC rebuked for not disclosing texts over Pfizer vaccine dealIn an interview in April, von der Leyen revealed she had exchanged texts with Bourla for a month when they were negotiating a vaccine contr...
- Pfizer chief Albert Bourla wins $1 million Genesis Prize for development of COVID-19 vaccineThe $1 million award is granted each year to a person for their professional achievements, contributions to humanity and commitment to Jewi...
- Pfizer expects Omicron vaccine to be ready in MarchA vaccine focused directly on the Omicron variant would also guard against breakthrough infections of a strain that has proven highly conta...
- Pfizer working on updated jab in response to Omicron variant: CEOPfizer's chief executive Dr Albert Bourla told the BBC that he is of the view that annual vaccinations would be needed to maintain a "very ...
- Pfizer CEO says India vaccine nod is near, but official hints at indemnity hurdle“I hope very soon we will finalise an agreement with the government,” Bourla said at a virtual event organised by USA-India Chamber of Comm...
- Pfizer-BioNTech pledge 2 bn doses to less wealthy nationsAmerican pharmaceutical company Pfizer and German company BioNTech pledged on Friday to deliver 2 billion doses of their Covid-19 vaccine t...
- India reaches out to US companies over investment in pharmaceutical, medical devices sectorIndia's Ambassador to the US Taranjit Singh Sandhu has held virtual meetings with Alberta Bourla, the CEO of Pfizer, Thermo Fisher CEO Marc...
- Pfizer seeks quicker nod for vaccine, donates $70 million worth of drugsThe Indian government had last month allowed emergency use approval for imported vaccines which have been granted similar approvals by the ...
- Pharma major Pfizer donates ₹510 crore worth COVID-19 treatment drugs to India
- Pfizer donates USD 70 mn worth COVID-19 treatment drugs to IndiaThese medicines, valued at more than USD 70 million, will be made available immediately, said company's Chairman.
- Pfizer COVID-19 vaccine safe, effective in kids aged 12 to 15, companies sayPfizer hopes that vaccinations of the group could begin before the next school year, Albert Bourla, Pfizer's chairman and chief executive, ...
- Pfizer CEO confident of getting U.S. advisory panel nod for COVID-19 vaccineBourla, speaking on a call with reporters on Tuesday, also reiterated confidence in Pfizer's ability to deliver its mRNA vaccine, developed...
- Pfizer Inc's CEO offloaded 62% of his stock holdings post Covid-19 vaccine trial success announcementIn an SEC filing on late Tuesday, Bourla disclosed that he has sold 62 per cent of his stock holdings, or 1,32,508 shares, at $41.94 per sh...
- Pfizer replaces longtime CEO Read with veteran BourlaRead, who was appointed CEO in December 2010, will become the executive chairman of Pfizer's board from Jan. 1.
Load More
